---
figid: PMC9075660__pone.0266472.g006
figtitle: Working model for AICAR-mediated regulation of hepatic Fet-A expression
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
pmcid: PMC9075660
filename: pone.0266472.g006.jpg
figlink: /pmc/articles/PMC9075660/figure/pone.0266472.g006/
number: F6
caption: Metformin or AICAR increases the phosphorylation of AMPK, which activates
  p38 MAPK. As a result, AMPK-p38MAPK signaling suppresses high-glucose induced Fet-A
  expression either by increasing proteasomal degradation and/or by decreasing hepatic
  expression of C/EBP beta.
papertitle: AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPÎ²/E3
  Ubiquitin Ligase Signaling pathway.
reftext: Vishal Kothari, et al. PLoS One. 2022;17(5):e0266472.
year: '2022'
doi: 10.1371/journal.pone.0266472
journal_title: PLoS ONE
journal_nlm_ta: PLoS One
publisher_name: Public Library of Science
keywords: ''
automl_pathway: 0.9474393
figid_alias: PMC9075660__F6
figtype: Figure
organisms_ner:
- Bos taurus
redirect_from: /figures/PMC9075660__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9075660__pone.0266472.g006.html
  '@type': Dataset
  description: Metformin or AICAR increases the phosphorylation of AMPK, which activates
    p38 MAPK. As a result, AMPK-p38MAPK signaling suppresses high-glucose induced
    Fet-A expression either by increasing proteasomal degradation and/or by decreasing
    hepatic expression of C/EBP beta.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - COMP
  - MAPK14
---
